NASDAQ:CHNG
Delisted
Change Healthcare Inc. Stock News
$27.49
+0 (+0%)
At Close: Jan 27, 2023
Judge denies DOJ request to block UnitedHealth-Change acquisition
10:47am, Tuesday, 20'th Sep 2022
A U.S. judge has denied the Justice Department's effort to block UnitedHealth's bid to buy Change Healthcare. CNBC's David Faber breaks down the details.
Change Healthcare Stock Surges After Judge Overrules Antitrust Challenge
10:03am, Tuesday, 20'th Sep 2022
Reports just came out that a federal judge has ruled against the Department of Justice (DOJ) bid stopping UnitedHealth Group (UNH) from taking over Change Healthcare Inc (NASDAQ:CHNG).
Change Healthcare's stock is up after judge rules in favor of UnitedHealth acquisition
09:46am, Tuesday, 20'th Sep 2022
Shares of Change Healthcare Inc. CHNG, +7.05% jumped 7.0% in premarket trading on Tuesday, the day after a federal judge ruled in favor of UnitedHealth Group's UNH, -1.41% acquisition of the company,
Change Healthcare Stock Surges After UnitedHealth Merger Challenge Blocked
07:47am, Tuesday, 20'th Sep 2022
Citi downgrades Change Healthcare in wake of the news, saying the trial played out as it expected.
UnitedHealth Sees Court Win In Change Healthcare Acquisition Case
09:01pm, Monday, 19'th Sep 2022
A federal judge has ruled against a Justice Department antitrust challenge to UnitedHealth Group's $13 billion acquisition of Change Healthcare, a health tech firm, The Wall Street Journal reported Mo
Judge denies DOJ's request to block UnitedHealth's acquisition of Change Healthcare
08:01pm, Monday, 19'th Sep 2022
WASHINGTON — A federal judge Monday ruled against a Justice Department antitrust challenge to UnitedHealth Group Inc.'s UNH, +0.49% $13 billion acquisition of health-technology firm Change He
Here's Why You Should Retain Change Healthcare (CHNG) Stock
12:47pm, Tuesday, 06'th Sep 2022
Change Healthcare (CHNG) continues to benefit from strategic deals. However, intense competition remains a woe.
Change Healthcare Inc. (CHNG) CEO Neil de Crescenzo on Q1 2023 Results - Earnings Call Transcript
01:19pm, Saturday, 06'th Aug 2022
Change Healthcare Inc. (NASDAQ:CHNG ) Q1 2023 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants David Elliott - Vice President, Enterprise Strategy and Investor Relations Neil de
Change Healthcare (CHNG) Q1 Earnings and Revenues Miss Estimates
09:03pm, Wednesday, 03'rd Aug 2022
Change Healthcare (CHNG) delivered earnings and revenue surprises of -2.56% and 0.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Change Healthcare Inc. Announces Date for First Quarter Fiscal 2023 Earnings Release and Earnings Call
07:00am, Thursday, 21'st Jul 2022
NASHVILLE, Tenn.--(BUSINESS WIRE)--Change Healthcare Inc. Announces Date for First Quarter Fiscal 2023 Earnings Release and Earnings Call
Why Is Change Healthcare (CHNG) Up 0.5% Since Last Earnings Report?
03:30pm, Friday, 24'th Jun 2022 Zacks Investment Research
Change Healthcare (CHNG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Change Healthcare (CHNG) Up 0.5% Since Last Earnings Report?
01:14pm, Friday, 24'th Jun 2022
Change Healthcare (CHNG) reported earnings 30 days ago. What's next for the stock?
Change Healthcare (CHNG)-Luma Launch Patient Engagement Suite
04:04pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
Change Healthcare's (CHNG) latest launch is expected to significantly improve patients' healthcare journey and create a more streamlined patient experience.
UnitedHealth (UNH) Unit Eyes $1.5B EMIS Acquisition in UK
06:06pm, Tuesday, 21'st Jun 2022 Zacks Investment Research
UnitedHealth's (UNH) Optum business operates in the United Kingdom for two decades and the acquisition is expected to boost its footprint in the country.
Change Healthcare Inc. (CHNG) CEO Neil de Crescenzo on Q4 2022 Results - Earnings Call Transcript
06:22pm, Thursday, 26'th May 2022
Change Healthcare Inc. (NASDAQ:CHNG ) Q4 2022 Earnings Conference Call May 26, 2022 8:00 AM ET Company Participants David Elliott - Vice President, Enterprise Strategy & Investor Relations Neil de Cre